Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 5 days, and 1 more · Every feed →

All 30Congress 0Executive branch 0Insiders 30
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

ELVN · $100K+ · 30 trades

Trades
30
Buys 0 · Sells 30
People
8
Stocks
1
Disclosed value
$167M
range midpoints · Congress & executive
Filed late
2
  1. ▼ SELLJ. Scott Garland DirectorELVN Enliven Therapeutics, Inc.$607Kdisclosed Oct 5 · filed 4 days after the trade
  2. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$146Kdisclosed Sep 21 · filed 4 days after the trade
  3. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$177Kdisclosed Sep 21 · filed 4 days after the trade
  4. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$111Kdisclosed Sep 21 · filed 4 days after the trade
  5. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$228Kdisclosed Aug 19 · filed 2 days after the trade
  6. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$270Kdisclosed Aug 19 · filed 2 days after the trade
  7. ▼ SELLMika K Derynck DirectorELVN Enliven Therapeutics, Inc.$9.6Mdisclosed Aug 6 · filed 2 days after the trade
  8. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$134Kdisclosed Jul 21 · filed 4 days after the trade
  9. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$108Kdisclosed Jul 21 · filed 4 days after the trade
  10. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$117Kdisclosed Jul 21 · filed 4 days after the trade
  11. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$141Kdisclosed Jul 21 · filed 4 days after the trade
  12. ▼ SELLLori Anne Kunkel DirectorELVN Enliven Therapeutics, Inc.$205Kdisclosed Jul 8 · filed 2 days after the trade
  13. ▼ SELLLori Anne Kunkel DirectorELVN Enliven Therapeutics, Inc.$299Kdisclosed Jul 8 · filed 2 days after the trade
  14. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$1.1Mdisclosed Jun 24 · filed 2 days after the trade
  15. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$2.1Mdisclosed Jun 24 · filed 2 days after the trade
  16. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$2.1Mdisclosed Jun 24 · filed 2 days after the trade
  17. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$1.1Mdisclosed Jun 24 · filed 2 days after the trade
  18. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$1.1Mdisclosed Jun 24 · filed 2 days after the trade
  19. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$35.7Mdisclosed Jun 24 · filed 2 days after the trade
  20. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$35.7Mdisclosed Jun 24 · filed 2 days after the trade
  21. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$2.1Mdisclosed Jun 24 · filed 2 days after the trade
  22. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$35.7Mdisclosed Jun 24 · filed 2 days after the trade
  23. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$149Kdisclosed Jun 22 · filed 5 days after the trade · late
  24. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$114Kdisclosed Jun 22 · filed 5 days after the trade · late
  25. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$12.3Mdisclosed Jun 17 · filed 2 days after the trade